Unravelling mechanisms of p53-mediated tumour suppression.

Articles citing Unravelling mechanisms of p53-mediated tumour suppression.

Title / Author	Year
Regulation of the p53 response and its relationship to cancer DW Meek Biochemical Journal 469 (3), 325-346	2015
Mechanisms of ferroptosis JY Cao, SJ Dixon Cellular and Molecular Life Sciences 73 (11-12), 2195-2209	2016
p53 as a target for the treatment of cancer MJ Duffy, NC Synnott, PM McGowan, J Crown, D O’Connor, ... Cancer treatment reviews 40 (10), 1153-1160	2014
TP53: an oncogene in disguise T Soussi, KG Wiman Cell death and differentiation 22 (8), 1239	2015
The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches AC Joerger, AR Fersht Annual review of biochemistry 85, 375-404	2016
Aneuploidy and chromosomal instability in cancer: a jackpot to chaos M Giam, G Rancati Cell division 10 (1), 3	2015
Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche H Davis, S Irshad, M Bansal, H Rafferty, T Boitsova, C Bardella, E Jaeger, ... Nature medicine 21 (1), 62	2015
Organelle-specific initiation of autophagy V Sica, L Galluzzi, JM Bravo-San Pedro, V Izzo, MC Maiuri, G Kroemer Molecular cell 59 (4), 522-539	2015
Comparison of predicted and actual consequences of missense mutations LA Miosge, MA Field, Y Sontani, V Cho, S Johnson, A Palkova, ... Proceedings of the National Academy of Sciences 112 (37), E5189-E5198	2015
NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer AR Özeş, DF Miller, ON Özeş, F Fang, Y Liu, D Matei, T Huang, ... Oncogene 35 (41), 5350	2016
Targeting mutant p53 for efficient cancer therapy VJN Bykov, SE Eriksson, J Bianchi, KG Wiman Nature Reviews Cancer 18 (2), 89	2018
NOD-like receptors: master regulators of inflammation and cancer M Saxena, G Yeretssian Frontiers in immunology 5, 327	2014
The role of DNA damage responses in p53 biology D Speidel Archives of toxicology 89 (4), 501-517	2015
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53-or ATM-defective chronic lymphocytic leukemia cells M Kwok, N Davies, A Agathanggelou, E Smith, C Oldreive, E Petermann, ... Blood 127 (5), 582-595	2016
The role of microRNAs in colorectal cancer A Mohammadi, B Mansoori, B Baradaran Biomedicine & Pharmacotherapy 84, 705-713	2016
The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy SJ Woods, KM Hannan, RB Pearson, RD Hannan Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1849 (7), 821-829	2015
Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma M Köbel, AM Piskorz, S Lee, S Lui, C LePage, F Marass, N Rosenfeld, ... The Journal of Pathology: Clinical Research 2 (4), 247-258	2016
Glutaminolysis: a hallmark of cancer metabolism L Yang, S Venneti, D Nagrath Annual review of biomedical engineering 19, 163-194	2017
Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia L Wang, AN Brooks, J Fan, Y Wan, R Gambe, S Li, S Hergert, S Yin, ... Cancer cell 30 (5), 750-763	2016
The importance of p53 pathway genetics in inherited and somatic cancer genomes G Stracquadanio, X Wang, MD Wallace, AM Grawenda, P Zhang, J Hewitt, ... Nature reviews Cancer 16 (4), 251	2016

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.